Generic Drug Prices Falling in the U.S. – Realpharmacyrx Online Pharmacy Special Offers Buy generic Drugs at 15 % Discounted Prices

Finally, a little good health care news for consumers: U.S. prices for generic prescription, which cost as little as one-third what their trademark name cousins do, is getting cheaper and probably will continue to doing so every therapeutic segments of like Men’s Sexual health (Generic Viagra, Caverta, Kamagra, Kamagra Jelly Oral, Forzest, Tadalis (Tadalafil), Levitra and more ED products), Weight Loss Pills and Diet Pills (Acomplia, Slimona, Xenical, and alli), Heartburn, Acid reflux (Prilosec, Nexium, Prevacid, Protonix), Herpes and Anti Viral (Zovirax, Valtrex), Heart and Cholesterol Pills (Lipitor, Zocor) and much more medications at truly unbeatable prices (We help you to save more than 80% straight by buying Quality and brand equivalent Generics drugs instead of Brands).

The reasons? The ultra-low prices for generic prescription for every therapeutic segments of like Men’s Sexual health and more ED products), Weight Loss Pills and Diet Pills, Heartburn, Acid reflux, Herpes and Anti Viral, Heart and Cholesterol Pills (Lipitor, Zocor) and much more medications at truly unbeatable prices (We help you to save more than 80% straight by buying Quality and brand equivalent Generics drugs given to giant retailers and drugstore chains and intense competition in the range of generic drugmakers fighting for sales, according to Realpharmacyrx. Prices pressures forced down dollar sales of generic drugs in the U.S. by 2.7 percent in the year ending in September, although the number of generic prescription filled actually increased by 5.4 percent over the year before. “We are seeing the combination of pressure from large retailers that make generics available to more low-price for their customers” and the intensified competition in the generic drugmakers will lead them to cut prices every therapeutic segments.

Realpharmacyrx said the price competition is particularly egregious for the medicine had a brand-name blockbusters – recent example is the osteoporosis drug Fosamax and Cholesterol fighter Zocor – which “may have as many as 20 generic manufacturers competing for share.” Between now and 2012, brand-name drugs to $ 139 billion in annual sales in the top eight world markets will face generic competition, Realpharmacyrx known. Medicines that include the world of top-selling medicine, Pfizer Inc. ’s Cholesterol drug Lipitor, which has sales of nearly $ 13 billion a year. However, after that, the continued decline in the number of large new brand-name drugs are approved means fewer new generics.

Generics generate $ 78 billion in revenue in 26 countries with the highest sales in the year ending in September, an increase of only 3.6 percent the year before, Revenue was climbing by double digits for several years and take 11.4 percent in 2007. The report of the U.S. generic sales dipped from $ 34 billion in 2007 to $ 33 billion in the year ending in September, when generic drugs accounted for almost 64 percent of all prescriptions filled.

Among other major markets, revenue from generic drugs also declined in the UK, driven by price pressure from its national health system, but increased by double digits in France, Italy, Japan and Spain the cheap generic drugs.

IMS expects “seismic change” in the global generics industry in the next decade, as price pressures led to smaller generic manufacturers that profit margins are squeezed now captured by powerful players. Meanwhile, more large companies are branching out to developing brand-name drugs, more brand-name company trying to compensate for slow growth are making their own generics, and common versions of biotech drugs – not allowed in this country – is expected to become more common, extending the common market for all the products.